PTPRC and cancer: Subsequently, a research published on the nature journal demonstrated that the IFNγ secretion of CD8+ T cells activated by PD-L1 blockage promoted ferroptosis of CD45- ID8 cells, and combination of cyst(e)inase and PD-L1 blockage significantly increased the anti-cancer efficacy (18).